EXHIBIT I
JOINT FILING AGREEMENT
This will confirm the agreement by and among the undersigned that the Schedule 13G filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the Common Stock, par value $0.0001 per share, of ORIC Pharmaceuticals, Inc., a Delaware corporation, will be filed on behalf of each of the persons and entities named below in accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.
| Date: April 28, 2020 | TOPSPIN FUND L.P. | |
| By: | LG Management, LLC, its General Partner | |
| By: | /s/ Leo A. Guthart | |
| Leo A. Guthart, Managing Member of the General Partner | ||
| TOPSPIN BIOTECH FUND II, L.P. | ||
| By: | LG Management, LLC, its General Partner | |
| By: | /s/ Leo A. Guthart | |
| Leo A. Guthart, Managing Member of the General Partner | ||
| LG MANAGEMENT, LLC | ||
| By: | /s/ Leo A. Guthart | |
| Leo A. Guthart, Managing Member | ||
| LEO A. GUTHART | ||
| /s/ Leo A. Guthart | ||
